A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The protocol, approved by the Rwanda National Ethical Committee, was issued to assess the safety and efficacy of the circumcision device for applying it to the national scale up of adult male circumcision in Rwanda
| Condition | Intervention |
|---|---|
|
Male Circumcision HIV Prevention HIV Infections |
Device: The PrePex a novel device for adult male circumcision |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings |
- The efficacy and safety of The PrePex System for adult male circumcision in Rwanda [ Time Frame: 4 week post-procedure follow up appointment and examination ] [ Designated as safety issue: Yes ]
Outcome measures will include:
Number of Participants with Adverse Events as a Measure of Safety,
Pain as measured by Visual Analogue Scale (VAS),
Wound healing rate.
- Operational scalability to mass scale up program [ Time Frame: four week post-procedure follow up appointment and examination ] [ Designated as safety issue: No ]
Outome measure include:
Duration required by diffrent personnel to perform the procedure Procedure performance by nurses
- satisfaction & acceptability of patients [ Time Frame: 4 weeks follow up ] [ Designated as safety issue: No ]
Outcome measure include:
Quality of life and satisfaction questionnaire
- Guidelines for utility in scale up mass circumcision program [ Time Frame: 4 weeks follow up ] [ Designated as safety issue: No ]
Outcome measure includes:
Physicians questionnaire on the clinical and practical performance of the procedure
- compliance with post procedure instructions [ Time Frame: 4 weeks follow up ] [ Designated as safety issue: No ]
Outcome measure include:
Weekly follow up visits post procedure, compliance with post procedure instructions questionnaire
| Estimated Enrollment: | 50 |
| Study Start Date: | June 2010 |
| Study Completion Date: | December 2010 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Males undergoing circumcision |
Device: The PrePex a novel device for adult male circumcision
The PrePex System was designed to enable safe, effective, painless and bloodless male circumcision programs. The PrePex System includes a simple, disposable device that is easy to use and can be deployed by minimally trained healthcare professionals, without the need for sterile, hospital settings.
|
Detailed Description:
Multiple randomized and controlled studies (WHO, USAID, UNAIDS) have proven that circumcised men in high risk areas reduce their risk of HIV infection by 60%.
The Government of Rwanda has ranked HIV prevention as a top priority item, and wishes to decrease the HIV incidence in the country by 50%. As part of a holistic HIV prevention approach, we decided to embark upon a process of national scale up of adult male circumcision. The national HIV prevention plan calls for voluntary MC of 2 million adults by the end of 2012.
The PrePex System was designed to enable safe, effective, painless and bloodless male circumcision programs, to support global public health efforts to stop the spread of HIV.
The PrePex System includes a simple, disposable device that is easy to use and can be deployed by minimally trained healthcare professionals, in urban or rural settings, without the need for sterile, hospital settings. As such, The PrePex System places minimal burden on the existing health care infrastructure to accomplish national circumcision programs.
The protocol, approved by the Rwanda National Ethical Committee, was issued to assess the safety and efficacy of the circumcision device for applying it to the national scale up of adult male circumcision in Rwanda.
Eligibility| Ages Eligible for Study: | 18 Years to 54 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Male of ages 18 - 54 years
- Subject wants to be circumcised
- Uncircumcised
- HIV sero-negative Agrees to undergo measurements of width of the penis at different areas in flaccid status
- Able to understand the study procedures and requirements
- Agrees to abstain sexual intercourse and to keep caution not directly rub the cut area if masturbating, until the end of the follow-up that may take up to 6 weeks
- Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
Exclusion Criteria:
- Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision
- HIV sero-positive
- Subject with the following diseases: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias
- Diabetes mellitus
- Subject who have an abnormal penile anatomy or any penile diseases
- Subject that to the opinion of the investigator is not a good candidate
Contacts and Locations| Rwanda | |
| Kanombe Military Hospital | |
| Kigali, Rwanda, 3377 | |
| Principal Investigator: | Dr. Jean Paul Bitega, M.D. | Kanombe Military Hospital |
More Information
Additional Information:
No publications provided
| Responsible Party: | Ministry of Health, Rwanda |
| ClinicalTrials.gov Identifier: | NCT01150370 History of Changes |
| Other Study ID Numbers: | CMT-01 |
| Study First Received: | June 23, 2010 |
| Last Updated: | January 10, 2011 |
| Health Authority: | Rwanda: Ministry of health |
Keywords provided by Ministry of Health, Rwanda:
|
male circumcision HIV Rwanda HIV Seronegativity |
Additional relevant MeSH terms:
|
HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on June 18, 2013